[go: up one dir, main page]

NO975692D0 - Bifosfonater som forhindrer tap av benmasse i forbindelse med immunsuppressiv terapi - Google Patents

Bifosfonater som forhindrer tap av benmasse i forbindelse med immunsuppressiv terapi

Info

Publication number
NO975692D0
NO975692D0 NO975692A NO975692A NO975692D0 NO 975692 D0 NO975692 D0 NO 975692D0 NO 975692 A NO975692 A NO 975692A NO 975692 A NO975692 A NO 975692A NO 975692 D0 NO975692 D0 NO 975692D0
Authority
NO
Norway
Prior art keywords
biphosphonates
connection
bone loss
immunosuppressive therapy
prevent bone
Prior art date
Application number
NO975692A
Other languages
English (en)
Other versions
NO975692L (no
Inventor
Anastasia G Daifotis
Ashley J Yates
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO975692D0 publication Critical patent/NO975692D0/no
Publication of NO975692L publication Critical patent/NO975692L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO975692A 1995-06-06 1997-12-05 Bifosfonater som forhindrer tap av benmasse i forbindelse med immunsuppressiv terapi NO975692L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/471,466 US5616571A (en) 1995-06-06 1995-06-06 Bisphosphonates prevent bone loss associated with immunosuppressive therapy
PCT/US1996/008398 WO1996039151A1 (en) 1995-06-06 1996-06-03 Bisphosphonates prevent bone loss associated with immunosuppressive therapy

Publications (2)

Publication Number Publication Date
NO975692D0 true NO975692D0 (no) 1997-12-05
NO975692L NO975692L (no) 1997-12-05

Family

ID=23871741

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975692A NO975692L (no) 1995-06-06 1997-12-05 Bifosfonater som forhindrer tap av benmasse i forbindelse med immunsuppressiv terapi

Country Status (14)

Country Link
US (1) US5616571A (no)
EP (1) EP0831844A4 (no)
JP (1) JPH11507044A (no)
KR (1) KR19990022380A (no)
CA (1) CA2223400A1 (no)
CZ (1) CZ288906B6 (no)
EA (1) EA000964B1 (no)
HU (1) HUP9900886A3 (no)
IL (1) IL122149A (no)
NO (1) NO975692L (no)
NZ (1) NZ310000A (no)
PL (1) PL323797A1 (no)
SK (1) SK163797A3 (no)
WO (1) WO1996039151A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07501073A (ja) * 1991-11-22 1995-02-02 プロクター、エンド、ギャンブル、ファーマス−ティカルズ、インコーポレーテッド リゼドロネート遅延放出組成物
WO1996025165A1 (en) * 1995-02-17 1996-08-22 Merck & Co., Inc. Method of lessening the risk of non-vertebral bone fractures
BR9712197A (pt) * 1996-10-04 1999-08-31 Merck & Co Inc Formulação farmacêutica líquida aquosa e processos de preparação da mesma, e, de inibição de reabsorção de osso.
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
AU741818C (en) * 1997-07-22 2003-01-09 Merck Sharp & Dohme Corp. Method for inhibiting bone resorption
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
WO2000021542A1 (en) * 1998-10-15 2000-04-20 Merck & Co., Inc. Methods for stimulating bone formation
US6414006B1 (en) 1998-10-15 2002-07-02 Merck Frosst Canada & Co. Methods for inhibiting bone resorption
US6331533B1 (en) 1998-11-16 2001-12-18 Merck & Co., Inc. Method for inhibiting dental resorptive lesions
NZ515134A (en) 1999-05-04 2004-01-30 Strakan Ltd Androgen glycosides and androgenic activity thereof
AUPQ232599A0 (en) * 1999-08-19 1999-09-09 Royal Alexandra Hospital For Children, The Drug for treating fractures
US6677320B2 (en) * 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
EP1276482B1 (en) * 2000-03-02 2008-01-16 University Of Pittsburgh Of The Commonwealth System Of Higher Education Combination chemotherapy
KR20030083725A (ko) * 2001-03-01 2003-10-30 에미스페어 테크놀로지스, 인코포레이티드 비스포스포네이트 전달용 조성물
WO2003086415A1 (en) * 2002-04-05 2003-10-23 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
US20040097468A1 (en) * 2002-11-20 2004-05-20 Wimalawansa Sunil J. Method of treating osteoporosis and other bone disorders with upfront loading of bisphosphonates, and kits for such treatment
US20050181043A1 (en) * 2004-02-12 2005-08-18 Indranil Nandi Alendronate salt tablet compositions
US20050261250A1 (en) * 2004-05-19 2005-11-24 Merck & Co., Inc., Compositions and methods for inhibiting bone resorption
US20060134190A1 (en) * 2004-12-16 2006-06-22 Banner Pharmacaps Inc. Formulations of bisphosphonate drugs with improved bioavailability
WO2006102117A1 (en) * 2005-03-17 2006-09-28 Elan Pharma International Limited Nanoparticulate biphosphonate compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530603D0 (en) * 1985-12-12 1986-01-22 Leo Pharm Prod Ltd Chemical compounds
NZ246456A (en) * 1991-12-17 1997-03-24 Procter & Gamble Pharma Use of bone active phosphonate and a parathyroid hormone to prepare medicaments for a thirty day treatment regimen for osteoporosis
EP0648120B1 (en) * 1992-06-30 1997-12-29 PROCTER & GAMBLE PHARMACEUTICALS, INC. Use of phosphonates for the treatment of osteoporosis
US5578593A (en) * 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
JPH08505142A (ja) * 1992-12-23 1996-06-04 メルク エンド カンパニー インコーポレーテッド 骨損失を治療及び予防するためのビスホスホネート／エストロゲン療法
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
ZA956029B (en) * 1994-07-22 1997-01-20 Lilly Co Eli Combination treatment for inhibiting bone loss
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
CN1157566A (zh) * 1994-09-09 1997-08-20 普罗克特和甘保尔公司 用于骨质疏松症的膦酸盐类和甲状旁腺激素

Also Published As

Publication number Publication date
WO1996039151A1 (en) 1996-12-12
JPH11507044A (ja) 1999-06-22
KR19990022380A (ko) 1999-03-25
EA000964B1 (ru) 2000-08-28
US5616571A (en) 1997-04-01
EP0831844A1 (en) 1998-04-01
EA199800011A1 (ru) 1998-06-25
HUP9900886A3 (en) 2002-04-29
NZ310000A (en) 2000-07-28
AU696097B2 (en) 1998-09-03
IL122149A0 (en) 1998-04-05
NO975692L (no) 1997-12-05
IL122149A (en) 2001-03-19
CZ389897A3 (cs) 1998-07-15
PL323797A1 (en) 1998-04-27
SK163797A3 (en) 1998-07-08
HUP9900886A2 (hu) 2001-04-28
AU6030996A (en) 1996-12-24
CZ288906B6 (cs) 2001-09-12
CA2223400A1 (en) 1996-12-12
EP0831844A4 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
NO975692D0 (no) Bifosfonater som forhindrer tap av benmasse i forbindelse med immunsuppressiv terapi
FR2739911B3 (fr) Robinet tournant perfectionne
HUP9902463A3 (en) Fixture and prosthesis including the same
NO983692D0 (no) Skruegjengeimplantat
AU3745895A (en) Use of gaba antagonists in the treatment of emesis
FR2737847B1 (fr) Implant-taraud comprimant
GB2313317B (en) Speaking valves
GB9601993D0 (en) Tap
AU2160697A (en) Nsaids in the treatment of pruritus
ZA95183B (en) Tap
GB9518463D0 (en) Used water diverter
GB9625817D0 (en) Improvement in the lavatory
GB9613745D0 (en) Optical connection in HV line
GB9417854D0 (en) Tap spanner
IT238699Y1 (it) Rubinetto salva aria
BR7402441U (pt) Disposiçao construtiva em adaptador par torneira
GB9609635D0 (en) Stop tap
KR970006481A (ko) 장에서 집락화하는 유산간균
BR7301499U (pt) Disposição construtiva em encaixe odontológico
ITRM960826A0 (it) Sicur tap
AUPN867296A0 (en) The designer tap
KR970004549U (ko) 탭렌치
PL102040U1 (en) Three-way ball cock
NO944262D0 (no) Svingjern
IT235698Y1 (it) Rubinetto perfezionato

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application